| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14:30 | Baird reiterates JBT Marel stock rating on strong earnings outlook | ||
| 14:30 | National CineMedia stock rating maintained at Buy by Benchmark | ||
| 14:30 | D.A. Davidson reiterates Napco Security stock buy rating at $52 | ||
| 14:06 | Jeffs' Brands subsidiary signs distribution deal with Skyline | ||
| 14:06 | Callan JMB to oversee manufacturing for JKB-122 immune platform | ||
| 14:06 | Camden Property Trust promotes Jessett to CEO, Baker to president | ||
| 14:06 | VERSES AI completes second tranche of private placement | ||
| 14:06 | Jefferies reiterates Buy on Eli Lilly stock, $1,300 target | ||
| 14:06 | Bernstein reiterates McDonald's stock rating on Iran war impact | ||
| 14:06 | Baird reiterates Alliance Laundry stock rating on growth drivers | ||
| 14:06 | Bernstein reiterates Ferguson stock rating on data center proximity | ||
| 14:06 | Bernstein reiterates Netflix stock rating on price hike momentum | ||
| 13:54 | ECR Minerals shareholders approve all AGM resolutions | ||
| 13:54 | EQT Real Estate sells 7.3M sq ft logistics portfolio to Ares | ||
| 13:54 | LM Funding Q4 2025 slides: Bitcoin output rises amid margin pressure | ||
| 13:54 | One and One Green Technologies launches copper-gold recovery venture | ||
| 13:54 | Norwegian Cruise Line adds five directors, reaches deal with Elliott | ||
| 13:54 | Empery Digital rejects ATG Capital, Tice Brown director nominees | ||
| 13:54 | Hudson Technologies signs refrigerant reclamation deal with Solstice | ||
| 13:54 | ORIC Pharmaceuticals to report prostate cancer trial data Tuesday | ||
| 13:54 | Oppenheimer maintains Nike stock rating ahead of earnings | ||
| 13:54 | Wedbush reiterates Tesla stock Outperform rating at $600 target | ||
| 13:54 | FBN Securities cuts ServiceNow stock price target on valuation | ||
| 13:42 | Ultimate Products H1 FY26 slides: transformation amid revenue decline | ||
| 13:42 | Foresight Solar FY 2025 slides: operations excel despite 11% NAV drop |